LSE - Delayed Quote USD
CSX Corporation (0HRJ.L)
28.75
-0.29
(-1.00%)
At close: May 9 at 6:37:15 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 17 | 16 | 23 | 23 |
| Avg. Estimate | 3.57B | 3.6B | 14.25B | 14.89B |
| Low Estimate | 3.48B | 3.47B | 13.8B | 13.79B |
| High Estimate | 3.65B | 3.71B | 14.49B | 15.3B |
| Year Ago Sales | 3.7B | 3.62B | 14.54B | 14.25B |
| Sales Growth (year/est) | -3.41% | -0.57% | -2.01% | 4.48% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0HRJ.L | -- | -- | -- | -- |
| S&P 500 | 13.21% | 3.09% | 8.02% | 13.76% |
Upgrades & Downgrades
| Maintains | UBS: Buy to Buy | 4/17/2025 |
| Reiterates | Raymond James: Outperform to Outperform | 4/17/2025 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 4/17/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 4/17/2025 |
| Maintains | Barclays: Overweight to Overweight | 4/17/2025 |
| Maintains | BMO Capital: Outperform to Outperform | 4/17/2025 |